MALORIE IRWIN: Open Payments
NPI 1477925527 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,555 in 172 payments from 48 companies in 2025. Trend: 2023 $3,206 · 2024 $2,884 · 2025 $3,555
Food & beverage: $3,472Education: $83
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $473 |
| Daiichi Sankyo Inc. | 13 | $314 |
| AstraZeneca Pharmaceuticals LP | 15 | $291 |
| Novartis Pharmaceuticals Corporation | 12 | $249 |
| Merck Sharp & Dohme LLC | 7 | $147 |
| Celgene Corporation | 7 | $132 |
| PFIZER INC. | 8 | $131 |
| GlaxoSmithKline, LLC. | 7 | $130 |
| ABBVIE INC. | 6 | $125 |
| GENZYME CORPORATION | 4 | $89 |
Products named: Enhertu, RYBREVANT, REBLOZYL, IBRANCE, TALVEY, IMFINZI, KEYTRUDA, DATROWAY.
Industry payments across LA — which companies pay providers there.
